News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,086 Results
Type
Article (40871)
Company Profile (267)
Press Release (679938)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204653)
Career Advice (2022)
Deals (35531)
Drug Delivery (110)
Drug Development (81369)
Employer Resources (173)
FDA (16401)
Job Trends (14941)
News (346346)
Policy (32721)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49576)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (305)
Approvals (16666)
Artificial intelligence (500)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (631)
Cancer (4749)
Cardiovascular disease (395)
Career advice (1707)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (728)
Cervical cancer (36)
Clinical research (69485)
Collaboration (1666)
Company closure (4)
Compensation (1138)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (810)
Cystic fibrosis (143)
Data (6144)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6669)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90034)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117173)
Executive appointments (958)
FDA (19474)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1444)
Gene editing (191)
Generative AI (42)
Gene therapy (581)
GLP-1 (962)
Government (4651)
Grass and pollen (6)
Guidances (383)
Healthcare (18867)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (103)
Infectious disease (2965)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16638)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (638)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (776)
MASH (161)
Medical device (13753)
Medtech (13805)
Mergers & acquisitions (19950)
Metabolic disorders (1250)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2864)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4508)
Now hiring (65)
Obesity (586)
Opinion (256)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (469)
Peanut (55)
People (58804)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21664)
Phase 2 (30580)
Phase 3 (22788)
Pipeline (5071)
Policy (278)
Postmarket research (2564)
Preclinical (9190)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (813)
Real estate (5953)
Recruiting (69)
Regulatory (24409)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (86)
Weight loss (376)
Women's health (87)
Worklife (18)
Date
Today (14)
Last 7 days (591)
Last 30 days (2224)
Last 365 days (29789)
2026 (2811)
2025 (30172)
2024 (35216)
2023 (40076)
2022 (51175)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39188)
Australia (6404)
California (11153)
Canada (3249)
China (1082)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84413)
Florida (1660)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (850)
India (62)
Indiana (513)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (7985)
Michigan (319)
Minnesota (621)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2965)
New Mexico (28)
New York (2939)
North Carolina (1435)
North Dakota (8)
Northern California (5435)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2252)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4339)
Tennessee (172)
Texas (1718)
United States (39531)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,086 Results for "somalogic inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Standard BioTools Completes Sale of SomaLogic to Illumina
February 1, 2026
·
6 min read
Press Releases
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
June 23, 2025
·
9 min read
Deals
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic’s Proposed Merger with Standard BioTools
Dr. Larry Gold, the founder of SomaLogic, Inc. and Dr. Jason Cleveland, SomaLogic’s current Chief Technology Officer, are issuing the below letter to SomaLogic’s stockholders regarding their opposition to the Company’s proposed merger with Standard BioTools, Inc. .
December 28, 2023
·
5 min read
Deals
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting
SomaLogic, Inc., a leader in proteomics technology, announced that, based on the preliminary vote count provided by its proxy solicitors following the Company’s Special Meeting of Stockholders held earlier today, SomaLogic stockholders voted to approve the transaction with Standard BioTools Inc. .
January 4, 2024
·
7 min read
BioMidwest
SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders
SomaLogic, Inc., a leader in proteomics technology, sent the following open letter to stockholders reiterating the Board’s belief that the proposed transaction between SomaLogic and Standard BioTools is in the best interest of all stockholders.
December 29, 2023
·
17 min read
Deals
Standard BioTools Stockholders Approve Merger with SomaLogic
Standard BioTools Inc., driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic at its Special Meeting of Stockholders.
January 4, 2024
·
7 min read
Deals
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
SomaLogic, Inc. issued an open letter to stockholders highlighting the value maximizing merger entered into with Standard BioTools on October 4, 2023.
December 21, 2023
·
16 min read
BioMidwest
SomaLogic expands agreement with Novo Nordisk to 2025
SomaLogic, Inc., a leader in proteomics technology, announced that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk.
September 5, 2023
·
4 min read
Deals
SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure
SomaLogic, Inc., a leader in proteomics technology, issued the following statement in response to a press release issued by Madryn Asset Management, LP on December 26, 2023, regarding the pending merger with Standard BioTools.
December 26, 2023
·
17 min read
BioMidwest
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting “FOR” Pending Merger with Standard BioTools
SomaLogic, Inc., a leader in proteomics technology, sent the following open letter to stockholders urging them to vote “FOR” the value maximizing transaction with Standard BioTools.
January 2, 2024
·
15 min read
1 of 72,109
Next
